The 'go to' European specialist pharma company
First ever UK survey of patient experiences with hepatic encephalopathy commissioned* by the British Liver Trust and Liver4Life, shows that out of 33 anonymous respondents;
*Survey supported by an unrestricted educational grant from Norgine.
1Norgine data on file: Results of the 2014 survey of patients and carers with hepatic encephalopathy
Rifaximin technology appraisal guidance now published https://t.co/pt5cqf95MO
Norgine is committed to improving the lives of patients suffering with hepatic encephalopathy, a debilitating disease
First ever UK survey of patient experiences with hepatic encephalopathy shows need to improve diagnosis & need to reduce hospitalisations
Norgine’s commitment to improving quality in colonoscopy is exemplified by this partnership